Real-World Comparison of Liquid and Tissue Biopsy NGS for Actionable Mutations in Advanced NSCLC: Clinical Utility and Implications in Argentina
Diego Hernán Enrico, Delfina Dibarbora, Lucía D. Espeche, María Florencia Cantarella et autres
Introduction: Comprehensive molecular testing is essential in advanced non-small cell lung cancer (aNSCLC) given its prognostic and therapeutic implications. Tissue- and plasma-based next-generation sequencing (NGS) offer complementary molecular profiling approaches. However, implementation in Argentina faces challenges, mainly economic barriers. We evaluated the …
ar (code pays fourni par la source)
0 citations
The Journal of Liquid Biopsy